Brief: Vivesto Reports Positive Topline Results From Paccal Vet Study In Cats
17/09/2026 14:12
BRIEF-Vivesto Reports Positive Topline Results From Paccal Vet Study In Cats Sept 17 (Reuters) - Vivesto AB VIVE.ST:
REPORTS POSITIVE TOPLINE RESULTS FROM PACCAL VET STUDY IN CATS
PRELIMINARY RESULTS SHOW ANTI-TUMOR EFFECT IN 21 CATS ACROSS MULTIPLE TUMOR TYPES
FINAL ANALYSED RESULTS ARE EXPECTED IN THE FOURTH QUARTER OF 2026
Source text: ID:nMFN6lWGl9
Further company coverage: VIVE.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Vivesto AB
See all newsBrief: Vivesto Reports Positive Topline Results From Paccal Vet Study In Cats
Brief: Vivesto Says Topline Results For Paccal Vet 'Positive'
Brief: Vivesto Q2 Operating Loss At SEK 8.6 Mln
Brief: Vivesto: Positive Results From Exploratory Study With Cantrixil
Brief: Vivesto Appoints Björn Svanström As CFO